Krakatoa LLC – Trademark Portfolio

Entity Type: 16

Krakatoa LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 34 (Smokers Articles) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BULA KING, BULA SHOT, KAVA DEPOT, SOLOMON GOLD, and BOTANY EVOLUTION. The owner is based in Palm Bay, FL.

2510 Kirby Circle NE, Suite 110

2510 Kirby Circle NE, Suite 110

Palm Bay, FL 32905

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Krakatoa LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

34
Smokers Articles (1 filing)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Krakatoa LLC have?

Krakatoa LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 2 cancelled.

What trademark classes does Krakatoa LLC file in?

Krakatoa LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 34 (Smokers Articles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Krakatoa LLC's most well-known trademarks?

Krakatoa LLC's registered trademark portfolio includes well-known marks such as BULA KING, BULA SHOT, KAVA DEPOT, SOLOMON GOLD, and BOTANY EVOLUTION. These are among 6 currently registered trademarks in the portfolio.

What is Krakatoa LLC's trademark registration success rate?

Krakatoa LLC has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.